MORGUARD REIT(TSX:MRT-DB-A) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, MRT-DB-A scores 2 out of 10 in our fundamental rating. MRT-DB-A was compared to 43 industry peers in the Diversified REITs industry. MRT-DB-A has a bad profitability rating. Also its financial health evaluation is rather negative. MRT-DB-A has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

MRT-DB-A had negative earnings in the past year.

In the past year MRT-DB-A had a positive cash flow from operations.

In the past 5 years MRT-DB-A reported 4 times negative net income.

In the past 5 years MRT-DB-A always reported a positive cash flow from operatings.

1.2 Ratios

MRT-DB-A has a Return On Assets (-2.71%) which is comparable to the rest of the industry.

MRT-DB-A has a Return On Equity (-6.65%) which is comparable to the rest of the industry.

With a decent Return On Invested Capital value of 4.69%, MRT-DB-A is doing good in the industry, outperforming 72.09% of the companies in the same industry.

MRT-DB-A had an Average Return On Invested Capital over the past 3 years of 4.53%. This is in line with the industry average of 5.49%.

The 3 year average ROIC (4.53%) for MRT-DB-A is below the current ROIC(4.69%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-2.71%
ROE	-6.65%
ROIC	4.69%

ROA(3y)-3.2%

ROA(5y)-4.67%

ROE(3y)-7.53%

ROE(5y)-10.61%

ROIC(3y)4.53%

ROIC(5y)4.4%

1.3 Margins

MRT-DB-A has a Operating Margin of 48.10%. This is in the lower half of the industry: MRT-DB-A underperforms 62.79% of its industry peers.

MRT-DB-A's Operating Margin has declined in the last couple of years.

With a Gross Margin value of 49.57%, MRT-DB-A is not doing good in the industry: 76.74% of the companies in the same industry are doing better.

MRT-DB-A's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	48.1%
PM (TTM)	N/A
GM	49.57%

OM growth 3Y-1.47%

OM growth 5Y-1.92%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.99%

GM growth 5Y-2.03%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MRT-DB-A is destroying value.

MRT-DB-A has less shares outstanding than it did 1 year ago.

MRT-DB-A has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, MRT-DB-A has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.25 indicates that MRT-DB-A is not in any danger for bankruptcy at the moment.

MRT-DB-A has a Altman-Z score of 3.25. This is amongst the best in the industry. MRT-DB-A outperforms 88.37% of its industry peers.

MRT-DB-A has a debt to FCF ratio of 22.64. This is a negative value and a sign of low solvency as MRT-DB-A would need 22.64 years to pay back of all of its debts.

MRT-DB-A has a worse Debt to FCF ratio (22.64) than 60.47% of its industry peers.

MRT-DB-A has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.

MRT-DB-A has a Debt to Equity ratio (1.15) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.15
Debt/FCF	22.64
Altman-Z	3.25

ROIC/WACC0.65

WACC7.24%

2.3 Liquidity

MRT-DB-A has a Current Ratio of 0.05. This is a bad value and indicates that MRT-DB-A is not financially healthy enough and could expect problems in meeting its short term obligations.

MRT-DB-A has a Current ratio of 0.05. This is amonst the worse of the industry: MRT-DB-A underperforms 95.35% of its industry peers.

MRT-DB-A has a Quick Ratio of 0.05. This is a bad value and indicates that MRT-DB-A is not financially healthy enough and could expect problems in meeting its short term obligations.

MRT-DB-A has a Quick ratio of 0.05. This is amonst the worse of the industry: MRT-DB-A underperforms 95.35% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.05
Quick Ratio	0.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.09% over the past year.

Looking at the last year, MRT-DB-A shows a small growth in Revenue. The Revenue has grown by 1.61% in the last year.

MRT-DB-A shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.04% yearly.

EPS 1Y (TTM)14.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-27.29%

Revenue 1Y (TTM)1.61%

Revenue growth 3Y2.39%

Revenue growth 5Y-1.04%

Sales Q2Q%2.4%

3.2 Future

Based on estimates for the next years, MRT-DB-A will show a very strong growth in Earnings Per Share. The EPS will grow by 219.37% on average per year.

The Revenue is expected to decrease by -1.23% on average over the next years.

EPS Next Y820%

EPS Next 2Y219.37%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-6.64%

Revenue Next 2Y-1.23%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MRT-DB-A reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

A Price/Forward Earnings ratio of 137.24 indicates a quite expensive valuation of MRT-DB-A.

MRT-DB-A's Price/Forward Earnings is on the same level as the industry average.

MRT-DB-A's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	137.24

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MRT-DB-A is on the same level as its industry peers.

81.40% of the companies in the same industry are cheaper than MRT-DB-A, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	117.82
EV/EBITDA	60.43

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

MRT-DB-A's earnings are expected to grow with 219.37% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y219.37%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.49%, MRT-DB-A is a good candidate for dividend investing.

With a Dividend Yield of 4.49, MRT-DB-A pays less dividend than the industry average, which is at 8.03. 81.40% of the companies listed in the same industry pay a better dividend than MRT-DB-A!

MRT-DB-A's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.

		Industry Rank	Sector Rank
Dividend Yield	4.49%

5.2 History

The dividend of MRT-DB-A decreases each year by -24.29%.

MRT-DB-A is new to the dividend game and has less than 3 years of track record.

Dividend Growth(5Y)-24.29%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

MRT-DB-A has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-26%

EPS Next 2Y219.37%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MORGUARD REIT

TSX:MRT-DB-A (2/21/2025, 7:00:00 PM)

99.8

-0.1 (-0.1%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)02-12 2025-02-12

Earnings (Next)04-29 2025-04-29

Inst Owners0.62%

Inst Owner ChangeN/A

Ins Owners15.29%

Ins Owner ChangeN/A

Market Cap6.42B

Analysts50

Price Target110.22 (10.44%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.49%

Yearly Dividend0.24

Dividend Growth(5Y)-24.29%

DP-26%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-0.93%

PT rev (3m)9.26%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-7.69%

EPS NY rev (3m)-7.69%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.44%

Revenue NY rev (3m)-0.73%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	137.24
P/S	24.76
P/FCF	117.82
P/OCF	117.82
P/B	7.26
P/tB	7.26
EV/EBITDA	60.43

EPS(TTM)-1

EYN/A

EPS(NY)0.73

Fwd EY0.73%

FCF(TTM)0.85

FCFY0.85%

OCF(TTM)0.85

OCFY0.85%

SpS4.03

BVpS13.75

TBVpS13.75

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.71%
ROE	-6.65%
ROCE	6.89%
ROIC	4.69%
ROICexc	4.71%
ROICexgc	4.71%
OM	48.1%
PM (TTM)	N/A
GM	49.57%
FCFM	21.01%

ROA(3y)-3.2%

ROA(5y)-4.67%

ROE(3y)-7.53%

ROE(5y)-10.61%

ROIC(3y)4.53%

ROIC(5y)4.4%

ROICexc(3y)4.55%

ROICexc(5y)4.42%

ROICexgc(3y)4.55%

ROICexgc(5y)4.42%

ROCE(3y)6.57%

ROCE(5y)6.31%

ROICexcg growth 3Y6.46%

ROICexcg growth 5Y4.22%

ROICexc growth 3Y6.46%

ROICexc growth 5Y4.22%

OM growth 3Y-1.47%

OM growth 5Y-1.92%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.99%

GM growth 5Y-2.03%

F-Score6

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	1.15
Debt/FCF	22.64
Debt/EBITDA	8.18
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	1.95
Cash Conversion	43.66%
Profit Quality	N/A
Current Ratio	0.05
Quick Ratio	0.05
Altman-Z	3.25

F-Score6

WACC7.24%

ROIC/WACC0.65

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)14.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-27.29%

EPS Next Y820%

EPS Next 2Y219.37%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.61%

Revenue growth 3Y2.39%

Revenue growth 5Y-1.04%

Sales Q2Q%2.4%

Revenue Next Year-6.64%

Revenue Next 2Y-1.23%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y2.68%

EBIT growth 3Y0.89%

EBIT growth 5Y-2.94%

EBIT Next Year-3.48%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-17.89%

FCF growth 3Y-12.1%

FCF growth 5Y-9.44%

OCF growth 1Y-17.89%

OCF growth 3Y-12.1%

OCF growth 5Y-9.44%

MORGUARD REIT (MRT-DB-A.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens